News - EV71, Genetics


Current filters:


Popular Filters

NicOx appoints financial partner to assess Duchenne Muscular Dystrophy treatment


French biotechnology firm NicOx (Euronext Paris: COX) has granted an undisclosed financial partner an…


Ipsen’s Dysport next generation shows safety and efficacy in Phase III

Ipsen’s Dysport next generation shows safety and efficacy in Phase III


French drugmaker Ipsen today announced the results of the international Phase III clinical trial of Dysport…


UCB launches online search for rare phenotypes

UCB launches online search for rare phenotypes


Belgian drugmaker UCB (Euronext Brussels: UCB) has launched an online search to find rare phenotypes…

GeneticsGlobalPharmaceuticalRare diseasesResearchUCB

Nuevolution signs licensing agreement with Novartis

Nuevolution signs licensing agreement with Novartis


Denmark-based Nuevolution has entered into a non-exclusive technology licensing agreement with Swiss…

BiotechnologyDenmarkGeneticsLicensingNorthern EuropeNovartisNuevolutionResearch

Scotland demonstrates its collaborative approach to cell therapy development

Scotland demonstrates its collaborative approach to cell therapy development


Scottish stem cell companies Sistemic and Roslin Cells say they are working together with c to make the…

BiotechnologyEuropeGeneticsResearchRoslin CellsSistemic

arGEN-X R&D milestone triggers payment from Shire


Belgium-based preclinical stage biotech firm arGEN-X has announced a key milestone in its SIMPLE Antibody…


US regenerative medicine market to increase at a CAGR of 15.8%


The US regenerative medicine market has been forecast to increase at a compound annual growth rate (CAGR)…

BiotechnologyGeneticsMarkets & MarketingNorth America

Potential Duchenne drug expected to complete phase III trial this year


Dutch biotech company Prosensa says it has made progress with its Duchenne treatments, with six exon…


Stem cell company ReNeuron gets backing from Welsh government


UK-based stem cell company ReNeuron (AIM: RENE) will relocate to Wales after Arthurian Life Sciences,…


Genomics England's priorities announced on 65th anniversary of the UK's NHS


The chief executive of the Association of the British Pharmaceutical Industry (ABPI) has welcomed the…


Next generation sequencing market expected to grow to $2.7 billion by 2017


The next generation sequencing (NGS) market has been forecast to increase at a compound annual growth…

BiotechnologyEuropeGeneticsIlluminaMarkets & MarketingNorth America

US Supreme Court issues mixed ruling on DNA patents


The US Supreme Court yesterday (June 13) delivered its unanimous decision regarding the Association for…

BiotechnologyGeneticsLegalMyriad GeneticsNorth AmericaPatents

Genetics and genomics industry in the USA has a trillion dollar impact, new Battelle study shows


A new Battelle study released this week by United for Medical Research illustrates the genetics and genomics…

BiotechnologyFinancialGeneticsNorth AmericaResearch

Sinovac Biotech flu vaccine OKed in Mexico; EV71 results; financials


In what was a busy news day for Sinovac Biotech (Nasdaq: SVA), a leading provider of vaccines in China,…

BiotechnologyEV71FinancialRegulationResearchSinovac BiotechSouth America

Treatment with old drug suramin corrects autism symptoms in mouse model


Testing a new theory, researchers at the University of California, San Diego School of Medicine have…


Ethris enters SNIM modified RNA alliance with Shire


German biotech firm Ethris GmbH has initiated a research based alliance focused on the development and…

BiotechnologyEthris GmbHGeneticsLicensingPharmaceuticalResearchShire

EU funds Population Genetics in leukemia study consortium


The largest ever genomic study of relapsed acute lymphoblastic leukemia (ALL), the most common malignant…

FinancialGeneticsOncologyPharmaceuticalPopulation Genetics TechnologiesResearch

Emerging discoveries offer opportunities for uncommon genetic disorders


Groundbreaking therapies are on the horizon as scientists explore new treatment options for rare genetic…

BiotechnologyGeneticsMarkets & MarketingPharmaceuticalResearch

Back to top